NCT00716443View on ClinicalTrials.gov

Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections

PHASE4TerminatedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Nasolabial Folds
Interventions
DRUG

tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream)

Apply tetracaine/lidocaine cream once on one side of the face prior to Restylane® injections

DRUG

benzocaine 20% / lidocaine 6% / tetracaine 4% ointment

apply benzocaine / lidocaine / tetracaine ointment once on the other side of the face prior to Restylane® injections

Trial Locations (4)

10021

Sadick Dermatology, New York

33180

Skin and Cancer Associates, Center for Cosmetic Enhancement, Aventura

33401

Palm Beach Esthetic Dermatology and Laser Center, West Palm Beach

99204

Premier Clinical Research, Spokane

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00716443 - Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections | Biotech Hunter | Biotech Hunter